Clinical trial
Open, Multi-center, Non-interventional, Prospective/ Retrospective Observational Study on Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
NCT04798690 is registered in ClinicalTrials.gov with Dong-A ST Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open, Multi-center, Non-interventional, Prospective/ Retrospective Observational Study on Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
- Lead sponsor
- Dong-A ST Co., Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 8, 2021
- Completion date
- February 28, 2035
- Enrollment
- 5,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
growth hormone deficiency, idiopathic short stature, small for gestational age, turner syndrome